Literature DB >> 31550557

Impact of diabetic neuropathy severity on foot clearance complexity and variability during walking.

Eneida Yuri Suda1, Alessandra Bento Matias1, Sicco A Bus2, Isabel C N Sacco3.   

Abstract

BACKGROUND: The control of foot trajectory during swing phase is important to achieve safe clearance with the ground. Complexity of a physiological control system arises from the interaction of structural units and regulatory feedback loops that operate to enable the organism to adapt to a non-static environment. Diabetic polyneuropathy (DPN) impairs peripheral feedback inputs and alters ankle control during gait, which might affect toe clearance (ToC) parameters and its complexity, predisposing DPN-subjects to tripping and falling. RESEARCH QUESTION: How do different DPN-severity degrees change ToC trajectory and minimum ToC, and its complexity during gait of diabetic subjects?
METHODS: 15 healthy controls and 69 diabetic subjects were assessed and classified into DPN-severity degrees by an expert fuzzy model: absent (n = 26), mild (n = 21) and severe (n = 22). Three-dimensional kinematics was measured during comfortable walking. ToC was the minimum vertical distance between the marker placed at the first metatarsal head and the ground during swing. Mean ToC, ToC standard deviation (SD) between trials, and sample entropy (SaEn) and standard deviation (SD) of ToC trajectory were calculated from the ToC temporal series. ANOVA and ANCOVA (with the walking speed as the covariate) and Bonferroni pairwise post-hoc tests (P < 0.05) were used to compare groups.
RESULTS: Mean ToC and ToC SD did not show differences between groups (ANCOVA F = 0.436; df = 3; P = 0.705; F=1.719; df=3; P=0.170, respectively). ToC trajectory SD also did not show differences between groups (ANCOVA F = 3.98; df = 3; P = 0.755). Severe-DPN subjects showed higher ToC_Traj_SaEn than controls (ANCOVA F=2.60; df=3; P = 0.05). SIGNIFICANCE: Severe-DPN subjects showed a more complex pattern of overall foot-ankle trajectory in swing phase in comparison to controls, although did not present lower minimum ToC values. The higher complexity of ToC might lead to an increase in the motor system output (more strategies, increase in variability), resulting in a more unstable system and selected motor strategies.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complexity; Diabetic polyneuropathies; Falling; Foot clearance; Gait; Kinematics

Mesh:

Year:  2019        PMID: 31550557     DOI: 10.1016/j.gaitpost.2019.09.014

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  5 in total

1.  Gait Parameters and Peripheral Neuropathy in Patients With Diabetes: A Meta-Analysis.

Authors:  Zhenchao Wang; Si Peng; Honghong Zhang; Hong Sun; Ji Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-01       Impact factor: 6.055

2.  Association of toe-extension movement pattern magnitude and variability during three functional tasks with diabetic foot complications.

Authors:  Jennifer A Zellers; Hana J Bernhardson; Hyo-Jung Jeong; Paul K Commean; Ling Chen; Michael J Mueller; Mary K Hastings
Journal:  Clin Biomech (Bristol, Avon)       Date:  2021-05-03       Impact factor: 2.063

3.  Wearable Health Technology to Quantify the Functional Impact of Peripheral Neuropathy on Mobility in Parkinson's Disease: A Systematic Review.

Authors:  Marta Francisca Corrà; Elke Warmerdam; Nuno Vila-Chã; Walter Maetzler; Luís Maia
Journal:  Sensors (Basel)       Date:  2020-11-19       Impact factor: 3.576

4.  Application of vibration to the soles reduces minimum toe clearance variability during walking.

Authors:  Prabhat Pathak; Jeongin Moon; Se-Gon Roh; Changhyun Roh; Youngbo Shim; Jooeun Ahn
Journal:  PLoS One       Date:  2022-01-04       Impact factor: 3.240

5.  Longitudinal prediction of falls and near falls frequencies in Parkinson's disease: a prospective cohort study.

Authors:  Beata Lindholm; Christina Brogårdh; Per Odin; Peter Hagell
Journal:  J Neurol       Date:  2020-09-24       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.